Teladoc Health Inc. (TDOC) saw its stock soar 6.8% in the after-hours session on Monday, following an announcement of a new collaboration with Amazon (AMZN) to expand access to Teladoc's cardiometabolic programs.
The partnership allows eligible Amazon customers to directly find and enroll in Teladoc's diabetes, hypertension, pre-diabetes, and weight management programs through Amazon's Health Benefits Connector. This streamlines the enrollment process and improves accessibility to Teladoc's virtual chronic care solutions.
According to Teladoc CEO Chuck Divita, the collaboration aligns with the company's strategy to deliver greater value across its integrated offerings. By enabling seamless program discovery and enrollment on Amazon's platform, the partnership aims to help more people conveniently manage their health conditions.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。